Biogen and Ionis report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC
Go back to Biogen and Ionis report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 190.52 -1.64 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $192.16 | 52 Week High | $333.65 | |||
| Open | $191.75 | 52 Week Low | $223.02 | |||
| Day High | $192.56 | P/E | 24.39 | |||
| Day Low | $189.52 | EPS | $7.81 | |||
| Volume | 1,512,006 | |||||
| (NASDAQ: IONS) | Delayed: 40.81 -0.1 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.91 | 52 Week High | $62.68 | |||
| Open | $41.00 | 52 Week Low | $19.59 | |||
| Day High | $41.53 | P/E | N/A | |||
| Day Low | $40.77 | EPS | $0.00 | |||
| Volume | 990,649 | |||||
